SEC Form 4 · accession 0000899243-17-008731
CytomX Therapeutics, Inc. · CTMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Mark J Levin
10% Owner
Robert I Tepper
10% Owner
Kevin P Starr
10% Owner
THIRD ROCK VENTURES LP
10% Owner
TRV GP, LLC
10% Owner
Third Rock Ventures GP, L.P.
10% Owner
Period of report
Mar 23, 2017
Accepted (ET)
Mar 27, 2017 · 7:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501989
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 23, 2017 | S | 1,000,000 | $17.0002 | D | 5,820,348 | D | |
| Common StockF2,F1 | Mar 27, 2017 | S | 650,000 | $18.0003 | D | 5,170,348 | D | |
| Common StockF3 | holding | — | — | — | 59,776 | D | ||
| Common StockF4 | holding | — | — | — | 59,776 | D | ||
| Common StockF5 | holding | — | — | — | 59,777 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are directly held by Third Rock Ventures, L.P. ("TRV"). The general partner of TRV is Third Rock Ventures GP, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC"). The individual managers of TRV GP LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
- F2This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.45, inclusive. Each of the reporting persons undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
- F3These shares are directly held by Starr.
- F4These shares are directly held by Levin.
- F5These shares are directly held by Tepper.